Vividion Therapeutics Company
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Investors
Founded Date:
2013
Total Funding:
$236.5M
Investor Type:
For Profit
Employee Number:
101-250
Funding Status:
Late Stage Venture
Technology:
Anti-infective Drugs
Last Funding Type:
Series B
Investors Number:
12
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Estimated Revenue:
$50M to $100M